- Home
- NVST vs ACAD Comparison
NVST vs ACAD Comparison
Compare NVST & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- ACAD
- Stock Information
- Founded
- NVST 2018
- ACAD 1993
- Country
- NVST United States
- ACAD United States
- Employees
- NVST N/A
- ACAD N/A
- Industry
- NVST Medical/Dental Instruments
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- NVST Health Care
- ACAD Health Care
- Exchange
- NVST Nasdaq
- ACAD Nasdaq
- Market Cap
- NVST 3.3B
- ACAD 2.8B
- IPO Year
- NVST 2019
- ACAD 2004
- Fundamental
- Price
- NVST $20.48
- ACAD $17.89
- Analyst Decision
- NVST Hold
- ACAD Buy
- Analyst Count
- NVST 13
- ACAD 19
- Target Price
- NVST $20.32
- ACAD $26.17
- AVG Volume (30 Days)
- NVST 1.9M
- ACAD 4.2M
- Earning Date
- NVST 02-05-2025
- ACAD 02-25-2025
- Dividend Yield
- NVST N/A
- ACAD N/A
- EPS Growth
- NVST N/A
- ACAD N/A
- EPS
- NVST N/A
- ACAD 0.78
- Revenue
- NVST $2,503,300,000.00
- ACAD $929,236,000.00
- Revenue This Year
- NVST N/A
- ACAD $36.78
- Revenue Next Year
- NVST $2.62
- ACAD $8.19
- P/E Ratio
- NVST N/A
- ACAD $23.02
- Revenue Growth
- NVST N/A
- ACAD 47.06
- 52 Week Low
- NVST $15.15
- ACAD $14.15
- 52 Week High
- NVST $24.79
- ACAD $29.29
- Technical
- Relative Strength Index (RSI)
- NVST 61.01
- ACAD 54.79
- Support Level
- NVST $18.31
- ACAD $16.61
- Resistance Level
- NVST $19.40
- ACAD $18.23
- Average True Range (ATR)
- NVST 0.61
- ACAD 0.72
- MACD
- NVST 0.17
- ACAD -0.02
- Stochastic Oscillator
- NVST 100.00
- ACAD 47.74
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.